![]() |
市场调查报告书
商品编码
1800893
2025 年至 2033 年电生理设备市场报告(依产品、适应症(心房颤动、室上性心动过速、房室结折返性心动过速、沃尔夫-帕金森-怀特综合征、心动过缓等)、最终用户和地区划分Electrophysiology Devices Market Report by Product, Indication (Atrial Fibrillation, Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia, Wolff-Parkinson-White Syndrome, Bradycardia, and Other), End User, and Region 2025-2033 |
2024年,全球电生理设备市场规模达67亿美元。展望未来, IMARC Group预计到2033年,市场规模将达到129亿美元,2025-2033年期间的复合年增长率(CAGR)为7.58%。心律不整病例的增加、技术的进步、对微创手术的需求不断增长、医疗支出的增加、门诊护理环境的扩大、优惠的报销政策、早期诊断意识的提升以及人工智能(AI)在医疗器械中的应用,都是推动市场增长的一些因素。
心律不整盛行率上升
心房颤动 (AF) 等心律不整以及其他各种恶性疾病的盛行率不断上升,推动着市场的成长。根据行业报告,心房颤动 (AF),即心臟的电信号/颤动问题,在美国影响近 270 万人。 AF 是中风和心臟衰竭的最常见原因,给医疗服务带来了越来越重的负担。此外,技术进步和可支配收入的不断增长也提高了患者对心律不整的认识,因此他们更倾向于早期诊断和治疗。
电生理设备的技术进步
电生理设备市场的成长主要得益于科技的快速进步。 3D映射系统和其他创新技术使心臟科医师能够设计特定的心臟电活动模型,从而改善心律不整患者的诊断和治疗。此外,导管消融技术的改进有助于降低手术风险,同时最大限度地缩短患者的康復时间并提高成功率。同时,机器人辅助系统在电生理学中的应用也提高了手术的精确度和控制力,这为市场成长提供了显着的推动力。
微创手术的成长
微创 (MI) 电生理手术可以缩短恢復时间、缩短住院时间并降低手术风险,因此其在患者治疗中的需求量庞大。用于治疗心律不整的导管消融术等手术,比标准手术创伤更小。这进一步提高了诊断的准确性,并改善了治疗效果,同时降低了手术成本并减轻了患者的负担。此外,影像和测绘技术的发展也使 MI 介入更加简便,从而促进了市场的成长。
诊断设备占大部分市场份额
诊断设备细分市场的成长动力源自于心血管疾病(尤其是心律不整)日益增长的盛行率,这些疾病需要精确诊断才能有效治疗。诸如改进的心电图 (ECG) 和 EP 映射系统等技术进步正在提高诊断准确性,从而推动这些设备的广泛应用。此外,人们对早期发现和预防心臟疾病的认识不断提高,也推动了对动态心电图 (Holter) 和植入式心臟监视器 (ICM) 等诊断工具的需求。医疗保健提供者越来越依赖这些设备进行持续监测和精准资料收集,从而改善患者的预后。微创诊断程序的兴起,可以缩短患者恢復时间并减少住院时间,进一步促进了该细分市场的成长。
心房颤动(AF)占据业界最大份额
心房颤动 (AF) 细分市场的发展受到全球 AF 盛行率不断上升的推动,尤其是在老年人口中,AF 是导致中风和心臟衰竭的主要原因。随着人们对 AF 的认识不断加深,对早期诊断和有效治疗的需求也日益增长,这促使医疗保健提供者投资先进的电生理设备。 3D 映射系统和导管消融技术等诊断工具的技术进步提高了 AF 检测的准确性和治疗成功率,从而促进了 AF 的普及。此外,人们对微创手术的日益青睐,因为这种手术可以缩短恢復时间并减少併发症,这进一步加速了 AF 管理中对电生理设备的需求。
医院是主要的细分市场
医院细分市场的成长动力源自于心血管疾病(尤其是心律不整)日益增长的盛行率,这些疾病需要专门的电生理治疗。医院配备了先进的技术,例如3D映射和导管消融系统,使其能够提供全面的心臟护理。微创手术的需求日益增长,这些手术通常在医院环境中进行,进一步推动了医院细分市场的发展。此外,医院拥有能够处理复杂电生理治疗的熟练医疗专业人员,增强了患者在这些机构就诊的信心。医疗保健支出的不断增长,尤其是在已开发地区,使得医院能够投资尖端电生理设备,从而提升其诊疗能力。
北美引领市场,占据最大的电生理设备市场份额
该报告还对所有主要区域市场进行了全面分析,包括北美(美国和加拿大);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告指出,北美是电生理设备最大的区域市场。
从电生理设备市场动态来看,北美区域市场受老龄化人口中心血管疾病(尤其是心房颤动)盛行率上升的驱动。先进的医疗基础设施和尖端医疗技术的广泛普及,支持了该地区电生理设备的普及。人们对心臟病早期诊断和治疗的认识不断提高,也推动了对这些设备的需求。此外,人们对微创手术的日益青睐,也增加了导管消融术和其他电生理工具的使用。医疗技术的不断进步,例如3D映射系统和人工智慧(AI)集成,提高了手术的准确性和疗效,使其对患者和医疗保健提供者都更具吸引力,从而进一步推动了电生理设备的需求。
(请注意,这只是关键参与者的部分列表,完整列表在报告中提供。)
The global electrophysiology devices market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.9 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. Rising cardiac arrhythmia cases, technological advancements, growing demand for minimally invasive procedures, increasing healthcare expenditure, expanding outpatient care settings, favorable reimbursement policies, escalating awareness of early diagnosis, and the integration of artificial intelligence (AI) in medical devices are some of the factors driving the market growth.
Rising Prevalence of Cardiac Arrhythmias
Increasing prevalence of cardiac arrhythmias such as atrial fibrillation (AF) and various other malignant are driving the market growth. According to the industry reports, atrial fibrillation (AF), known as the electrical or signaling/flutter problem in the heart, is affecting almost 2.7 million people in United States. AF is the most common cause of strokes and heart failure, which is creating a growing burden on health services. In addition, expanding technological advancements and disposable income has boosted awareness about arrhythmias among patients, due to which they prefer early diagnosis and treatment.
Technological Advancements in Electrophysiology Devices
The growth of the electrophysiology devices market is primarily bolstered by the rapid technological advancements. 3D mapping systems and other innovations enable cardiologists to design specified models of the heart's electrical activity, which improves diagnosis and treatment for patients suffering with arrhythmias. Additionally, the improvements in catheter ablation technologies helps reduce procedural risks, while minimizing patient recovery times and increasing success rates. In line with this, the use of robotic-assisted systems in electrophysiology has also improved the precision and control during procedures, which is providing a considerable boost to the market growth.
Growth of Minimally Invasive Procedures
Minimally invasive (MI) electrophysiology procedures can reduce recovery times, hospital stays, and procedural risks, which is why they are witnessing a considerable demand for the treatment of patients. Procedures such as catheter ablation, which are used to treat arrhythmias, provide a less traumatic alternative to the standard surgeries. This further enables an accurate diagnosis and enhances the results of treatment at a reduced cost and strain of surgeries on patients. Apart from this, the development of imaging and mapping technologies, in turn, has made MI interventions less cumbersome, which is facilitating the market growth.
Diagnostic devices accounts for the majority of the market share
The diagnostic devices segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require precise diagnosis for effective treatment. Technological advancements, such as improved electrocardiographs (ECGs) and EP mapping systems, are enhancing diagnostic accuracy, leading to wider adoption of these devices. Additionally, the growing awareness of early detection and prevention of heart conditions is boosting demand for diagnostic tools like Holter monitors and insertable cardiac monitors (ICMs). Healthcare providers are increasingly relying on these devices for continuous monitoring and accurate data collection, which improves patient outcomes. The rise in minimally invasive diagnostic procedures, which offer quicker recovery times and reduce the need for hospital stays, is further contributing to the segment's growth.
Atrial fibrillation (AF) holds the largest share of the industry
The atrial fibrillation (AF) segment is driven by the increasing global prevalence of AF, particularly among aging populations, which is a leading cause of stroke and heart failure. As awareness about AF grows, there is a rising demand for early diagnosis and effective treatment, prompting healthcare providers to invest in advanced electrophysiology devices. Technological advancements in diagnostic tools, such as 3D mapping systems and catheter ablation technologies, have improved the accuracy of AF detection and treatment success rates, boosting adoption. Additionally, the growing preference for minimally invasive procedures, which offer faster recovery times and reduced complications, is further accelerating demand for electrophysiology devices in AF management.
Hospitals represents the leading market segment
The hospital segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require specialized electrophysiology procedures. Hospitals are equipped with advanced technology, such as 3D mapping and catheter ablation systems, enabling them to offer comprehensive cardiac care. The growing demand for minimally invasive procedures, which are often performed in hospital settings, further fuels this segment. Additionally, hospitals have skilled healthcare professionals capable of handling complex electrophysiology treatments, which boosts patient confidence in seeking care at these facilities. Rising healthcare expenditure, particularly in developed regions, allows hospitals to invest in cutting-edge electrophysiology devices, enhancing their capabilities.
North America leads the market, accounting for the largest electrophysiology devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for electrophysiology devices.
As per the electrophysiology devices market dynamics, the North America's regional market is driven by the increasing prevalence of cardiovascular diseases, particularly atrial fibrillation, among the aging population. Advanced healthcare infrastructure and widespread access to cutting-edge medical technologies support the adoption of electrophysiology devices across the region. Rising awareness of early diagnosis and treatment of heart conditions is boosting demand for these devices. Additionally, the growing preference for minimally invasive procedures has increased the use of catheter ablation and other electrophysiology tools. Continuous advancements in medical technology, such as 3D mapping systems and artificial intelligence (AI) integration, enhance the accuracy and outcomes of procedures, making them more attractive to both patients and healthcare providers, which is further driving the electrophysiology devices demand.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)